Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Bruce E. Sands, William J. Sandborn, Brian G. Feagan et al.|Journal of Crohn s and Colitis|2018

Cited by 115